News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Kohei Shitara: Pleased To Report FGFR2b Expression In Gastric Cancer and Relationship With Other Biomarkers Published in ESMO Open
Kohei Shitara/X
Jun 15, 2025, 08:16

Kohei Shitara: Pleased To Report FGFR2b Expression In Gastric Cancer and Relationship With Other Biomarkers Published in ESMO Open

Kohei Shitara, Medical Oncologist at National Cancer Center Hospital East, Japan, shared a post on X:

“Pleased to report FGFR2b expression in gastric cancer and relationship with other biomarkers in ESMO Open.
The results of bemarituzumab phase 3 studies are awaited.”

FGFR2b

Title: Clinical characterization of FGFR2b expression in patients with advanced gastric or gastroesophageal junction adenocarcinoma

Journal: ESMO Open

Authors: S. Sato, S.L. Rhodes, Y. Aoki, I. Nakayama, T. Hashimoto, J. Hawkins, R.E. Yanes, C.-H. Chang, Y. Nakamura, A. Kawazoe, S. Mishima, D. Kotani, Y. Kuboki, H. Bando, T. Kojima, S. Yoshino, S. Reading, H. Honeycutt, E. Finger, I. Endo, N. Sakamoto, T. Kuwata, T. Yoshino, K. Shitara

Read the full article.

FGFR2b

More posts featuring Kohei Shitara on OncoDaily.

A. Kawazoe C.-H. Chang cancer D. Kotani E. Finger ESMO Open FGFR2b gastric cancer H. Bando H. Honeycutt I. Endo I. Nakayama J. Hawkins K. Shitara Kohei shitara N. Sakamoto OncoDaily Oncology R.E. Yanes S. Mishima S. Reading S. Sato S. Yoshino S.L. Rhodes T. Hashimoto T. Kojima T. Kuwata T. Yoshino Y. Aoki Y. Kuboki Y. Nakamura
Special Coverage
Blog
Jul 26, 2025, 22:05
SIOPE and EURORDIS-Rare Diseases Europe Call for the Introduction of a Dedicated "First-in-Child" Incentive in the Legislative Text
Blog
Jul 26, 2025, 21:46
Sendurai Mani: From Student to Speaker - My Journey Back to IISc
Insight
Jul 26, 2025, 21:30
Yan Leyfman: Managing Infection Risk in Myeloma - Time to Rethink IgRT?
Blog
Jul 26, 2025, 21:09
Ammira Al-Shabeeb: Travel Award Applications are Now Open for PMFG Summit 2025
Opinion
Jul 26, 2025, 20:53
Patrick Hwu: Sarcoma is Rare and Complex
Blog
Jul 26, 2025, 20:13
Ready to Take Your Cancer Research Career to the Next Level? - EACR
Blog
Jul 26, 2025, 20:00
EU’s Medicine Strategy is Focused on Supply Chains, But Overlooks the Deeper Risk
Blog
Jul 26, 2025, 19:45
Siddharth Sreemahadevan: I was Honored to Be Declared Second Runner-Up in the 8th SPEAK Lymphoma Programme
Opinion
Jul 26, 2025, 19:31
The AACR Immuno-Oncology Research Fellowships Provide $130,000 to Support Clinical Fellows
Blog
Jul 26, 2025, 19:14
Bishal Gyawali: Calling the Family of My Patients After They Have Passed Away - It’s the Least We Can Do
Blog
Jul 26, 2025, 18:41
Global Health Equity Starts with Action - UICC
Science
Jul 26, 2025, 18:38
Incorporating Evidence-Based Approaches for Patients With GI Cancers - Society for Integrative Oncology